QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 17:03 UTC · Public disclosure record

XRAYTICKER

Dentsply Sirona Inc.

BULLISH stock

Congress has disclosed 5 buys and 6 sells of XRAY (Dentsply Sirona Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

5
Buy
6
Sell
-1
Net
6
Active politicians
Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/B
1.45
no sector median
how it's calculated
P/B = price ÷ book value per share
$9.82 ÷ $6.78 = 1.45
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
93.9
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($2.0B + $2.0B net debt) ÷ $0.0B = $3.9B ÷ $0.0B = 93.9
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

11 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Gilbert Cisneros House SELL ◆ insider divergence · strong Self · 150 Main Street Trust > Bank of America 2025-01-08 29 days +1.9% $1K–$15K
0.1% of NW
27.2 ↗ filing
Gilbert Cisneros House SELL ◆ insider divergence · strong Self · 150 Main Street Trust > Bank of America 2025-01-07 30 days +3.2% $1K–$15K
0.1% of NW
62.9 ↗ filing
Lois Frankel House SELL Self 2021-12-05 41 days — $1K–$15K
0.3% of NW
15.7 ↗ filing
Lois Frankel House SELL Self 2021-12-03 43 days — $1K–$15K
0.3% of NW
22.3 ↗ filing
Lois Frankel House BUY Self 2019-05-09 0 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
Dean Phillips House BUY Self 2019-01-04 32 days — $1K–$15K
<0.1% of NW
75.9 ↗ filing
Lois Frankel House BUY Self 2018-05-15 0 days — $1K–$15K
0.3% of NW
75.9 ↗ filing
Alan Lowenthal House SELL Spouse 2017-01-20 5 days — $1K–$15K 40.4 ↗ filing
Alan Lowenthal House BUY Spouse 2016-10-14 1 days — $1K–$15K 75.9 ↗ filing
Michael Conaway House SELL Spouse 2016-09-12 3 days — $1K–$15K 75.9 ↗ filing
Thomas MacArthur House BUY Joint 2015-03-06 26 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in XRAY — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

0
Congress trades with insider convergence
2
…with insider divergence
26
Insider open-market trades

Of the congressional trades in XRAY, 0 coincided with corporate insiders moving the same way within 60 days, and 2 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-06-15 Gladden Brian T Director BUY $100K ↗ EDGAR
2026-06-15 HOSEIN CLYDE Director BUY $65K ↗ EDGAR
2026-06-12 MCKEON BRIAN P Director BUY $101K ↗ EDGAR
2026-06-12 MAZELSKY JONATHAN JAY Director BUY $101K ↗ EDGAR
2026-06-11 Barber Michael J Director BUY $150K ↗ EDGAR
2026-06-11 HOLDEN BETSY D Director BUY $100K ↗ EDGAR
2026-03-09 Forbes James D Director BUY $62K ↗ EDGAR
2026-03-09 LUCIER GREGORY T Director BUY $187K ↗ EDGAR
2026-03-03 Forbes James D Director BUY $67K ↗ EDGAR
2026-03-03 LUCIER GREGORY T Director BUY $315K ↗ EDGAR
2026-03-02 LUCIER GREGORY T Director BUY $393K ↗ EDGAR
2025-12-08 LUCIER GREGORY T Director SELL $916K ↗ EDGAR
2025-11-24 VARON LESLIE F Director BUY $100K ↗ EDGAR
2025-03-03 LUCIER GREGORY T Director BUY $250K ↗ EDGAR
2024-11-18 LUCIER GREGORY T Director BUY $92K ↗ EDGAR
2024-11-18 LUCIER GREGORY T Director BUY $92K ↗ EDGAR
2024-11-15 LUCIER GREGORY T Director BUY $18K ↗ EDGAR
2024-11-15 LUCIER GREGORY T Director BUY $18K ↗ EDGAR
2024-11-12 Campion Simon D C-suite BUY $200K ↗ EDGAR
2024-08-08 LUCIER GREGORY T Director BUY $200K ↗ EDGAR
2024-05-31 LUCIER GREGORY T Director BUY $100K ↗ EDGAR
2023-11-22 LUCIER GREGORY T Director BUY $314K ↗ EDGAR
2023-11-20 Campion Simon D C-suite BUY $297K ↗ EDGAR
2023-11-20 Coleman Glenn C-suite BUY $297K ↗ EDGAR
2023-05-02 BRANDT ERIC Director SELL 10b5-1 $261K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-06-15 Gladden Brian T Director BUY $100K
◆ insider 2026-06-15 HOSEIN CLYDE Director BUY $65K
◆ insider 2026-06-12 MCKEON BRIAN P Director BUY $101K
◆ insider 2026-06-12 MAZELSKY JONATHAN JAY Director BUY $101K
◆ insider 2026-06-11 Barber Michael J Director BUY $150K
◆ insider 2026-06-11 HOLDEN BETSY D Director BUY $100K
◆ insider 2026-03-09 Forbes James D Director BUY $62K
◆ insider 2026-03-09 LUCIER GREGORY T Director BUY $187K
◆ insider 2026-03-03 Forbes James D Director BUY $67K
◆ insider 2026-03-03 LUCIER GREGORY T Director BUY $315K
◆ insider 2026-03-02 LUCIER GREGORY T Director BUY $393K
◆ insider 2025-12-08 LUCIER GREGORY T Director SELL $916K
◆ insider 2025-11-24 VARON LESLIE F Director BUY $100K
◆ insider 2025-03-03 LUCIER GREGORY T Director BUY $250K
Congress 2025-01-08 Gilbert Cisneros SELL $1K–$15K
Congress 2025-01-07 Gilbert Cisneros SELL $1K–$15K
◆ insider 2024-11-18 LUCIER GREGORY T Director BUY $92K
◆ insider 2024-11-18 LUCIER GREGORY T Director BUY $92K
◆ insider 2024-11-15 LUCIER GREGORY T Director BUY $18K
◆ insider 2024-11-15 LUCIER GREGORY T Director BUY $18K
◆ insider 2024-11-12 Campion Simon D C-suite BUY $200K
◆ insider 2024-08-08 LUCIER GREGORY T Director BUY $200K
◆ insider 2024-05-31 LUCIER GREGORY T Director BUY $100K
◆ insider 2023-11-22 LUCIER GREGORY T Director BUY $314K

FAQ Common questions

How much has Congress traded XRAY?

5 disclosed buys and 6 sells of XRAY (Dentsply Sirona Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade XRAY?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.